Prometheus Biosciences (RXDX)

Prometheus Biosciences Stock Analysis & Ratings

RXDX Stock Chart & Stats

Day’s Range$27.22 - $30.94
52-Week Range$17.25 - $51.96
Previous Close$27.52
Average Volume (3M)345.36K
Market Cap$1.19B
P/E Ratio-11.3
Next EarningsMay 12, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score8
EPS (TTM)-2.68



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Prometheus Biosciences’s price range in the past 12 months?
Prometheus Biosciences lowest stock price was $17.25 and its highest was $51.96 in the past 12 months.
    What is Prometheus Biosciences’s market cap?
    Prometheus Biosciences’s market cap is $1.19B.
      What is Prometheus Biosciences’s price target?
      The average price target for Prometheus Biosciences is $52.50. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $62.00 ,the lowest forecast is $45.00. The average price target represents 72.98% Increase from the current price of $30.35.
        What do analysts say about Prometheus Biosciences?
        Prometheus Biosciences’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
          When is Prometheus Biosciences’s upcoming earnings report date?
          Prometheus Biosciences’s upcoming earnings report date is May 12, 2022 which is 5 days ago.
            How were Prometheus Biosciences’s earnings last quarter?
            Prometheus Biosciences released its earnings results on Mar 09, 2022. The company reported -$0.77 earnings per share for the quarter, missing the consensus estimate of -$0.679 by -$0.091.
              Is Prometheus Biosciences overvalued?
              According to Wall Street analysts Prometheus Biosciences’s price is currently Undervalued.
                Does Prometheus Biosciences pay dividends?
                Prometheus Biosciences does not currently pay dividends.
                What is Prometheus Biosciences’s EPS estimate?
                Prometheus Biosciences’s EPS estimate is -$0.82.
                  How many shares outstanding does Prometheus Biosciences have?
                  Prometheus Biosciences has 39,100,000 shares outstanding.
                    What happened to Prometheus Biosciences’s price movement after its last earnings report?
                    Prometheus Biosciences reported an EPS of -$0.77 in its last earnings report, missing expectations of -$0.679. Following the earnings report the stock price went up 16.759%.
                      Which hedge fund is a major shareholder of Prometheus Biosciences?
                      Among the largest hedge funds holding Prometheus Biosciences’s share is Perceptive Advisors LLC. It holds Prometheus Biosciences’s shares valued at 92M.


                        Prometheus Biosciences Stock Analysis

                        Smart Score
                        Price Target
                        ▲(72.98% Upside)
                        Strong Buy
                        The Prometheus Biosciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                        Learn more about TipRanks Smart Score

                        Company Description

                        Prometheus Biosciences

                        Prometheus Biosciences Inc is a biotechnology company pioneering a precision medicine approach to the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment and diagnosis of...

                        Similar Stocks
                        No data currently available

                        Popular Stocks

                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis